Rigel Pharmaceuticals
RIGL
#6656
Rank
A$1.13 B
Marketcap
A$60.23
Share price
-2.67%
Change (1 day)
-6.80%
Change (1 year)

EPS for Rigel Pharmaceuticals (RIGL)

EPS in 2026 (TTM): A$26.35

According to Rigel Pharmaceuticals's latest financial reports the company's current EPS (TTM) is A$26.55. In 2025 the company made an earnings per share (EPS) of A$30.41 an increase over its 2024 EPS that were of A$1.49.

EPS history for Rigel Pharmaceuticals from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A$26.35-13.36%
2025A$30.411944.44%
2024A$1.49
2022A-$5.11240%
2021A-$1.50-37.5%
2020A-$2.40-60%
2019A-$6.01-11.11%
2018A-$6.76-26.23%
2017A-$9.16-17.57%
2016A-$11.1225.42%
2015A-$8.86-42.72%
2014A-$15.47
2012A-$19.98

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Amgen
AMGN
A$26.11-1.64%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
A$10.70-59.71%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sangamo Therapeutics
SGMO
A-$0.57-102.15%๐Ÿ‡บ๐Ÿ‡ธ USA
ChemoCentryx
CCXI.defunct
A-$2.84-110.70%๐Ÿ‡บ๐Ÿ‡ธ USA